Want to join the conversation?
$REGN 2Q15 Call: Pivotal Phase 3 studies in the atopic dermatitis indication are fully enrolled and the company expects to report data from these studies in 1H16. Second pivotal study of Dupilumab in asthma is currently enrolling patients. This Phase 3 study will explore two doses of Dupilumab, 200 and 300 mg administered every other week.
$SBUX launched its annual “Starbucks for Life” competition in the U.S. and Canada. The winner of the competition will receive a credit of one drink or food item per day for a duration of 30 years.
$T shares rose 1.8%, as a big boost for the S&P 500. The company said its new streaming television service DirectTV has so far exceeded expectations.
$TXMD flying high.. anyone here to catch..?
$CMG crashing. There seems to be nothing good to read about this company.